HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

5-(4-chlorophenyl)-1-(4-methoxyphenyl)-3-trifluoromethylpyrazole acts in a reactive oxygen species-dependent manner to suppress human lung cancer growth.

AbstractPURPOSE:
5-(4-chlorophenyl)-1-(4-methoxyphenyl)-3-trifluoromethylpyrazole (SC-560) is a structural analog of celecoxib. Recent studies suggested that SC-560 inhibits the in vivo proliferation of colon and breast cancer cells to an extent similar to that observed in celecoxib, and that SC-560 exerts their growth inhibitory effects in a cyclooxygenase-independent manner.
METHODS:
In the current study, we sought to investigate the mechanism by which SC-560 inhibits the growth of human lung cancer cells.
RESULTS:
SC-560 more potently inhibited the growth of human A549, H460, and H358 lung cancer cell lines compared with that of human BEAS-2B normal bronchial epithelial cells. SC-560-induced growth inhibition was mainly due to the induction of cell-cycle arrest at the G1 phase without apoptosis induction. SC-560 rapidly and dose-dependently induced the generation of reactive oxygen species (ROS), followed by accumulation of cells at the G1 phase. Antioxidant pretreatment blocked the cell-cycle arrest and growth inhibition induced by SC-560. Combination treatment with other ROS-inducing agents such as alpha-tocopheryl succinate (TOS) augmented cellular response against SC-560, leading to synergistic apoptosis induction and growth suppression. Our data also showed that the apoptosis induced by combination treatment with SC-560 and TOS was mediated through ROS-dependent caspase activation.
CONCLUSION:
Collectively, our results demonstrate that SC-560 acts in a ROS-dependent manner to induce growth suppression in human lung cancer cells.
AuthorsEunmyong Lee, Moon-Kyung Choi, Hee-Jeong Youk, Cheol Hyeon Kim, Inn-Oc Han, Byung-Chul Yoo, Mi-Kyung Lee, Soo-Jeong Lim
JournalJournal of cancer research and clinical oncology (J Cancer Res Clin Oncol) Vol. 132 Issue 4 Pg. 223-33 (Apr 2006) ISSN: 0171-5216 [Print] Germany
PMID16362334 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Drug Combinations
  • Pyrazoles
  • Reactive Oxygen Species
  • SC 560
  • Vitamin E
  • Caspases
  • Tocopherols
Topics
  • Antineoplastic Agents (pharmacology)
  • Apoptosis (drug effects)
  • Caspases (metabolism)
  • Cell Cycle (drug effects)
  • Cell Proliferation (drug effects)
  • Drug Combinations
  • Drug Evaluation, Preclinical
  • Drug Synergism
  • Humans
  • Lung Neoplasms (pathology)
  • Models, Biological
  • Pyrazoles (administration & dosage, pharmacology)
  • Reactive Oxygen Species (pharmacology)
  • Tocopherols
  • Tumor Cells, Cultured
  • Vitamin E (administration & dosage, analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: